Literature DB >> 20668140

Mycobacterium avium complex cervical lymphadenitis in an immunocompetent adult.

Joshua B Christensen1, John Koeppe.   

Abstract

Nontuberculosis mycobacterial cervical lymphadenitis is a relatively common disease in immunocompetent children but a rare disease in immunocompetent adults. We report the diagnosis and treatment of Mycobacterium avium complex cervical lymphadenitis in an adult female. Our evaluation of immune competence, including gamma interferon (IFN-gamma) and interleukin-12 (IL-12) signaling, found no evidence of deficiency.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20668140      PMCID： PMC2944454          DOI： 10.1128/CVI.00208-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  27 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  [Cervical lymphadenitis due to Mycobacterium avium in an immunocompetent adult].

Authors:  Iván Pérez de Pedro; Primitivo de la Quintana-Beltrán; Pilar Bermúdez-Ruiz
Journal:  Enferm Infecc Microbiol Clin       Date:  2007-02       Impact factor: 1.731

3.  Fine needle aspiration diagnosis of mycobacterial lymphadenitis. Sensitivity and predictive value in the United States.

Authors:  E Ellison; P Lapuerta; S E Martin
Journal:  Acta Cytol       Date:  1999 Mar-Apr       Impact factor: 2.319

4.  Lymphadenitis caused by non-tuberculous mycobacteria in a university hospital in Taiwan: predominance of rapidly growing mycobacteria and high recurrence rate.

Authors:  Liang-Wen Ding; Chih-Cheng Lai; Li-Na Lee; Li-Min Huang; Po-Ren Hsueh
Journal:  J Formos Med Assoc       Date:  2005-12       Impact factor: 3.282

5.  Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age.

Authors:  K K Lai; K D Stottmeier; I H Sherman; W R McCabe
Journal:  JAMA       Date:  1984-03-09       Impact factor: 56.272

6.  Atypical mycobacterial lymphadenitis in an adult.

Authors:  G S Deepe; R Capparell; J D Coonrod
Journal:  Chest       Date:  1980-12       Impact factor: 9.410

7.  Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls.

Authors:  K A Shriner; G E Mathisen; M B Goetz
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

8.  Mycobacterial lymphadenitis in Western Australia.

Authors:  S C Pang
Journal:  Tuber Lung Dis       Date:  1992-12

Review 9.  Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling.

Authors:  M H Haverkamp; J T van Dissel; S M Holland
Journal:  Microbes Infect       Date:  2006-01-19       Impact factor: 2.700

10.  Hairy cell leukemia: association with disseminated atypical mycobacterial infection.

Authors:  R A Weinstein; H M Golomb; G Grumet; E Gelmann; G P Schechter
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860
View more
  2 in total

1.  Diversity of Mycobacterium avium subsp. hominissuis mycobacteria causing lymphadenitis, France.

Authors:  L Despierres; S Cohen-Bacrie; H Richet; M Drancourt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

2.  Attenuation of Helper T Cell Capacity for TH1 and TH17 Differentiation in Children With Nontuberculous Mycobacterial Infection.

Authors:  Tiffany A Claeys; Oscar Rosas Mejia; Samuel Marshall; Jason A Jarzembowski; Don Hayes; Natalie M Hull; Namal P M Liyanage; Robert H Chun; Cecille G Sulman; Anna R Huppler; Richard T Robinson
Journal:  J Infect Dis       Date:  2019-10-22       Impact factor: 5.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.